Cord Stem Cell Banking Market Size to Surpass USD 45.64 Billion with CAGR of 22% by 2030

Cord Stem Cell Banking Market analysis document gives wide-ranging analysis of the market structure and the evaluations of the various segments and sub-segments of the HEALTHCARE This market report takes into account the comprehension of business goals and requirements to bridge the gap by delivering the most proper and suitable solutions. This industry analysis report contains the company profiles, product specifications, capacity, production value, and market shares of each company for the forecasted period of 2023-2030. The winning Cord Stem Cell Banking Market report makes organization up to date with the profound knowledge of the global, regional and local market statistics.

Data Bridge Market Research analyses that the cord stem cell banking market, which was USD 9.3 billion in 2022, would rise up to USD 45.64 billion by 2030 and is expected to undergo a CAGR of 22% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

The data involved in the steadfast Cord Stem Cell Banking Market report can be very necessary when it comes to dominating the market or making a mark in the market as a new emergent. With this market research report it becomes simpler for customers to understand the various drivers and restraints impacting the market during the forecast period. Top market player analysis covered in Cord Stem Cell Banking Market research report brings into focus various strategies used by them which can be listed as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and many others that leads to increase their footprints in HEALTHCARE industry.

Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cord-stem-cell-banking-market

The growing number of cancer patients is a primary factor for the cord stem cell banking market. Cancer diseases such as multiple myeloma and leukemia can be well-treated by stem cell transplants. According to the Globocan 2020 statistics, there were about 467,965 new cancer cases in France, with a 185,621 mortality rate. Further, it has been witnessed that pairing cord blood and tissue storage with genetic testing services is a developing trend in the cord stem cell banking market.

Drivers

Increasing Demand for Cord Blood And Tissue Storage With Genetic Testing Services
It has been witnessed recently that the combination of cord blood and tissue storage with genetic testing services is a developing trend in the cord stem cell banking market. Such pairing is possible and efficient due to its complimentary services to the existing clients, thus helping in increasing their product portfolio. For instance, a genetic testing company called Natera launched the Evercord cord blood and tissue storage service that enables expectant parents to collect, store and retrieve cord blood from newborns and tissue for further medicinal use in transplantation and regenerative medicine applications. Thus, this will boost market growth.

Increasing Cancer Cases
According to the Globocan 2020 data, there were around 457,960 new cancer cases in the U.K., with lung, colon, prostate, and skin cancer being the most widespread types of cancer detected. As per the same source, Italy witnessed 415,269 new cancer cases and around 174,759 deaths. Stem cell transplants can effectively treat cancer diseases such as leukemia and multiple myeloma. By using stem cells, the blood-forming stem cells damaged at the time of chemotherapy can be restored. Thus, due to the growing number of cancer cases, cord stem cell banking is extensively used in research institutes and hospitals, which is further anticipated to grow significantly during the forecast period.

Recent Development

In 2021, BioTherapeutic Labs Corp and American CryoStem entered a collaboration agreement for stem cell research and development. BTL will sell CRYO's goods and services. The two companies will collaborate to create protocols that utilize CRYO's ATCell autologous mesenchymal stem cells and BTL's human umbilical cord-based product lines.

Some of the major players operating in the cord stem cell banking market are:

CBR Systems, Inc., (U.S.)
Cordlife (Singapore)
Cryo-Cell International, Inc., (U.S.)
ViaCord (U.S.)
Cryo-Save (Netherlands)
LifeCell International Pvt. Ltd. (India)
StemCyte India Therapeutics Pvt. Ltd (U.S.)
Global Cord Blood Corporation (China)
Smart Cells International Limited (U.K.)
Vita 34 1997 - 2023, Inc (Germany)
Lisata Therapeutics, 2023 (U.S.)
BrainStorm Cell Limited (U.S.)
Regrow Biosciences Pvt. Ltd. (India)

To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-cord-stem-cell-banking-market

https://dbmrbuisness.blogspot.com/2023/06/medical-display-market-is-probable-to.html

https://dbmrbuisness.blogspot.com/2023/06/teleradiology-market-to-observe.html

https://dbmrbuisness.blogspot.com/2023/06/ehealth-market-is-likely-to-grasp-cagr.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.